Marinomed Biotech AG | WebDisclosure

Basculer en Français

9842	Companies
197750	Keywords
128847	Articles
105183	Press releases

Home
Companies
Marinomed Biotech AG

PRESS RELEASE

published on 09/15/2024 at 17:49, 1 year 4 months ago

EQS-Adhoc: Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case excluding statutory subscription rights
Marinomed Biotech AG sets price range for potential 10% capital increase and second capital increase, excluding statutory subscription rights

Capital Increase Marinomed Biotech AG Price Range Authorized Capital 2024 Restructuring Proceedings
BRIEF

published on 09/11/2024 at 07:50, 1 year 5 months ago

Marinomed Biotech AG: First Carragelose Products Receive New Medical Device Regulation (MDR) Certification

Regulatory Compliance Medical Devices Carragelose MDR Certification Marinomed
BRIEF

published on 09/11/2024 at 07:50, 1 year 5 months ago

Marinomed Biotech AG : les premiers produits à base de carraghénane reçoivent la nouvelle certification du Règlement sur les dispositifs médicaux (MDR)

Dispositifs Médicaux Conformité Réglementaire Certification MDR Marinomé Carraghénose
PRESS RELEASE

published on 09/11/2024 at 07:45, 1 year 5 months ago

Marinomed Biotech AG: First Carragelose products receive new Medical Device Regulation (MDR) certification
Marinomed Biotech AG's first Carragelose products receive new Medical Device Regulation (MDR) certification, enhancing safety and value for the portfolio

Regulatory Compliance Medical Devices Marinomed Biotech AG MDR Certification Carragelose Products
BRIEF

published on 09/02/2024 at 17:51, 1 year 5 months ago

Marinomed Biotech AG Evaluates 10% Capital Increase

Investors Shares Capital Increase Restructuring Marinomed
BRIEF

published on 09/02/2024 at 17:51, 1 year 5 months ago

Marinomed Biotech AG évalue une augmentation de capital de 10 %

Actions Augmentation De Capital Investisseurs Restructuration Marinomé
PRESS RELEASE

published on 09/02/2024 at 17:46, 1 year 5 months ago

EQS-Adhoc: Marinomed Biotech AG evaluates possible 10% capital increase with exclusion of statutory subscription rights
Marinomed Biotech AG evaluates a possible 10% capital increase excluding statutory subscription rights to finance ongoing costs in restructuring proceedings. Management Board to discuss with selected investors for potential transaction

Capital Increase Management Board Marinomed Biotech AG Restructuring Proceedings Statutory Subscription Rights
BRIEF

published on 08/20/2024 at 18:05, 1 year 5 months ago

Marinomed Biotech AG Reports Preliminary Financial Figures for H1 2024

Financial Results Product Development Restructuring Proceedings Q2 Revenue Growth New Partnerships
BRIEF

published on 08/20/2024 at 18:05, 1 year 5 months ago

Marinomed Biotech AG publie ses résultats financiers préliminaires pour le premier semestre 2024

Résultats Financiers Développement De Produits Croissance Du Chiffre D'affaires Au Deuxième Trimestre Procédure De Restructuration Nouveaux Partenariats
PRESS RELEASE

published on 08/20/2024 at 18:00, 1 year 5 months ago

Marinomed Biotech AG reports preliminary financial figures for the first half of 2024
Marinomed Biotech AG reports preliminary financial figures for the first half of 2024, including a decline in revenues compared to 2023. The company aims to stabilize through restructuring and new partnerships

Restructuring Preliminary Results Financial Figures Partnerships Marinomed Biotech AG

Accesswire

Published on 02/11/2026 at 23:00, 1 hour 43 minutes ago

Reeflex Solutions Inc. Provides Bi-Weekly Status Update On MCTO
Published on 02/11/2026 at 23:00, 1 hour 43 minutes ago

FutureGen Industries Announces Closing of Private Placement
Published on 02/11/2026 at 22:30, 2 hours 13 minutes ago

Battery X Metals Announces Strategic Sale of Gold & Copper Project Consistent with Its 360° Battery Metals Value Chain Strategy Encompassing Exploration, Rebalancing and Recycling in Support of the Energy Transition
Published on 02/11/2026 at 22:30, 2 hours 13 minutes ago

Green Bridge Metals Announces Partnership with APEX to Support Regional Engagement in Minnesota
Published on 02/11/2026 at 22:30, 2 hours 13 minutes ago

Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025

View all ACCESSWIRE

EQS Group

Published on 02/11/2026 at 19:52, 4 hours 51 minutes ago

LR Health & Beauty SE lays foundation for positive future business performance with new financing structure
Published on 02/11/2026 at 19:50, 4 hours 52 minutes ago

EQS-Adhoc: LR HEALTH & BEAUTY SE REACHES AN AGREEMENT WITH BONDHOLDERS AND SHAREHOLDER REGARDING A COMPREHENSIVE RESTRUCTURING OF THE 2024/2028 BOND – EUR 20 MILLION IN NEW CAPITAL AND ...
Published on 02/11/2026 at 18:31, 6 hours 12 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/11/2026 at 18:00, 6 hours 43 minutes ago

Private Equity Holding AG: Net Asset Value as of January 31, 2026
Published on 02/11/2026 at 17:55, 6 hours 47 minutes ago

POS-Transaction in Own Shares

Les Echos

Published on 02/11/2026 at 17:45, 6 hours 58 minutes ago

Infotel : Stake held in AeroEx. A publisher of digital compliance and safety solutions for the aerospace industry.
Published on 02/11/2026 at 17:45, 6 hours 58 minutes ago

Infotel : Prise de participation dans AeroEx éditeur de solutions digitales de conformité et de sécurité pour l’industrie aéronautique.
Published on 02/11/2026 at 11:25, 13 hours 17 minutes ago

Innelec : Mise à disposition du rapport financier semestriel 2025-26
Published on 02/11/2026 at 08:00, 16 hours 43 minutes ago

Imerys-press-release French State acquisition stake Emili Lithium
Published on 02/11/2026 at 08:00, 16 hours 43 minutes ago

Imerys-communique-de-presse prise participation Etat Français Projet lithium Emili

View all LES ECHOS COMFI WIRE